Patent Assignment
Reel/Frame 044165/0884
Assignment of Assignor's Interest
Recorded: 2017-11-17
Pages: 6
Assignors
SINGH, SHARAT
Executed: 2017-09-22
JAIN, ANJALI
Executed: 2017-06-16
KONDRAGUNTA, VENKATESWARLU
Executed: 2017-06-16
Assignee
NESTEC S.A.
AVENUE NESTLÉ 55, VEVEY, 1800, SWITZERLAND
Covered Property
(1)
Methods for Establishing a Vedolizumab Dosing Regimen to Treat Patients with Irritable Bowel Disease
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger.
Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Assignment of Assignor's Interest
Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
Change of Name
Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
Assignment of Assignor's Interest
Jun 21, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 056635/0750 →